Anna C. Pavlick

In this engaging discussion, Dr. Anna C. Pavlick, a professor at Weill Cornell Medicine and a pioneer in cutaneous oncology, dives into the promising RP1 plus nivolumab combo for advanced melanoma. She highlights key findings from the IGNITE trial, showcasing its potential for patients who haven't responded to previous treatments. Dr. Pavlick emphasizes the combination's strong efficacy and low toxicity, while also touching on the exciting future of oncolytic viruses in melanoma therapy. A must-listen for anyone interested in cutting-edge cancer treatments!